NIH has launched a human trial for LASSARAB, a dual-purpose vaccine targeting Lassa fever and rabies. Early animal studies ...

The NIH announced the beginning of a phase 1 first-in-human trial of a vaccine for Lassa fever, a potentially fatal viral hemorrhagic disease for which there is no approved vaccine or treatment.

A renowned virologist and former vice-chancellor of Redeemer’s University, Prof. Oyewale Tomori, has warned that Lassa fever ...

A decade after the worst of the virus’ 40 outbreaks killed 11,300 people, individuals who still bear its physical and mental ...

The greatest gift that God gave to mankind is the environment. The environment includes the entire ecosystem, both living and ...